Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs.

Bousema T, Okell L, Shekalaghe S, Griffin JT, Omar S, Sawa P, Sutherland C, Sauerwein R, Ghani AC, Drakeley C.

Malar J. 2010 May 24;9:136. doi: 10.1186/1475-2875-9-136.

2.

Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission.

Ouédraogo AL, Bousema T, Schneider P, de Vlas SJ, Ilboudo-Sanogo E, Cuzin-Ouattara N, Nébié I, Roeffen W, Verhave JP, Luty AJ, Sauerwein R.

PLoS One. 2009 Dec 22;4(12):e8410. doi: 10.1371/journal.pone.0008410.

3.

Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis.

Zwang J, Olliaro P, Barennes H, Bonnet M, Brasseur P, Bukirwa H, Cohuet S, D'Alessandro U, Djimdé A, Karema C, Guthmann JP, Hamour S, Ndiaye JL, Mårtensson A, Rwagacondo C, Sagara I, Same-Ekobo A, Sirima SB, van den Broek I, Yeka A, Taylor WR, Dorsey G, Randrianarivelojosia M.

Malar J. 2009 Aug 23;8:203. doi: 10.1186/1475-2875-8-203.

4.

Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.

Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, Randrianasolo L, Ratsimbasoa A, Forlemu D, Moor VA, Traore A, Dicko Y, Dara N, Lameyre V, Diallo M, Djimde A, Same-Ekobo A, Gaye O.

Malar J. 2009 Jun 8;8:125. doi: 10.1186/1475-2875-8-125.

5.

The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum.

Sirima SB, Tiono AB, Gansané A, Diarra A, Ouédraogo A, Konaté AT, Kiechel JR, Morgan CC, Olliaro PL, Taylor WR.

Malar J. 2009 Mar 16;8:48. doi: 10.1186/1475-2875-8-48.

6.

Pharmacovigilance of antimalarial treatment in Uganda: community perceptions and suggestions for reporting adverse events.

Bukirwa H, Nayiga S, Lubanga R, Mwebaza N, Chandler C, Hopkins H, Talisuna AO, Staedke SG.

Trop Med Int Health. 2008 Sep;13(9):1143-52. doi: 10.1111/j.1365-3156.2008.02119.x. Epub 2008 Jul 8.

7.

Adherence and effectiveness of drug combination in curative treatment among children suffering uncomplicated malaria in rural Senegal.

Souares A, Lalou R, Sene I, Sow D, Le Hesran JY.

Trans R Soc Trop Med Hyg. 2008 Aug;102(8):751-8. doi: 10.1016/j.trstmh.2008.05.016.

PMID:
18603111
8.
9.

Current issues in pediatric medication adherence.

Matsui D.

Paediatr Drugs. 2007;9(5):283-8. Review.

PMID:
17927300
10.

[Tolerance of amodiaquine].

Brasseur P.

Med Trop (Mars). 2007 Jun;67(3):288-90. Review. French.

PMID:
17784684
11.
12.
13.

Pharmacovigilance of antimalarial treatment in Africa: is it possible?

Talisuna AO, Staedke SG, D'Alessandro U.

Malar J. 2006 Jun 16;5:50.

14.
15.
16.

A molecular marker for chloroquine-resistant falciparum malaria.

Djimdé A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourté Y, Coulibaly D, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV.

N Engl J Med. 2001 Jan 25;344(4):257-63.

17.

Safety monitoring of new anti-malarials in immediate post-marketing phase.

Edwards IR.

Med Trop (Mars). 1998;58(3 Suppl):93-6. Review.

PMID:
10212911
18.

Effects of artemisinin derivatives on malaria transmissibility.

Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, White NJ.

Lancet. 1996 Jun 15;347(9016):1654-8.

PMID:
8642959
19.

Rapid and simple method for isolating malaria DNA from fingerprick samples of blood.

Foley M, Ranford-Cartwright LC, Babiker HA.

Mol Biochem Parasitol. 1992 Jul;53(1-2):241-4. No abstract available.

PMID:
1501643

Supplemental Content

Support Center